China's critically ill, and well-heeled, add twist to outgoing medical tourism
Beijing
CHINA'S medical system could not stop the cancer eating at Guo Shushi's stomach. It roared back even after Mr Guo, a 63-year-old real estate developer, endured surgery, chemotherapy and radiation at two hospitals.
Then his son-in-law discovered online that - for a price - companies were willing to help critically ill Chinese people seek treatment abroad. Soon Mr Guo was at the Dana-Farber Cancer Institute in Boston, receiving a new immunotherapy drug, Keytruda, which is not available in China. In April, nearly four months later, his tumour has shrunk and his weight has gone up.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action
France's Casino supermarket chain to axe up to 3,200 jobs